A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Active, not recruitingOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Colon CancerLiver Tumors
Interventions
OTHER

blood draws

Patients will have 10 mL of peripheral venous blood drawn immediately prior to surgery, in the post anesthesia care unit (PACU), and at the first postoperative clinic visit for a total of 30 mL.

PROCEDURE

colectomy or hepatectomy

"Three small pieces of otherwise normal-appearing liver of 0.5-1 cm3 collected intraoperatively from patients in all four groups (including Group D). Because liver biopsy is less frequently performed during operations for benign colon lesions or Stage I-III colon cancers, this single aspect of the protocol can be made optional at the discretion of the surgical attending or the patient, however bloods and tissue from pathology will still be collected."

DIAGNOSTIC_TEST

Fibroscan test

This may be done either at a preoperative clinic setting or immediately prior to surgery.

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11725

Memorial Sloan Kettering Commack, Commack

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03432806 - A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors | Biotech Hunter | Biotech Hunter